Brian Skorney is Baird’s senior analyst covering Biotechnology. Prior to joining Baird in 2012, he was a senior vice president in equity research at Brean Murray Carrett & Co, a vice president in equity research at ThinkEquity, LLC, and a research analyst at Susquehanna International Group, LLC, all in the biotech/pharmaceutical industry. He also worked as a coordinator and lab manager at the Howard Hughes Medical Institute. In 2016, he was ranked by Thomson Reuters Analyst Awards (StarMine) as the No. 3 stock picker in Biotechnology. Brian received a BS in biological sciences from the University of Notre Dame and an MBA in finance from New York University.
A pair of editorials by VA leadership highlight VA's commitment to continued research and leadership in promoting health equity —including through the Veterans Choice Act and other new programs. Deputy Under Secretary for Health for Community Care Dr. Baligh R. Yehia and coauthors write, "As the largest integrated health care system in the nation, VA has an opportunity to lead the rest of the country in reducing health and health care disparities ." Explore further: Study uncovers high prevalence of military sexual trauma among transgender veterans
The views and information contained within this Web site are provided for informational purposes only, are not meant as investment advice, and are subject to change. This material is for institutional investors and market counterparties only. The information does not constitute an offer to sell any securities in any jurisdiction in which such distribution is not authorized or where they are not available for distribution in the jurisdiction for the reader. If you have accessed this Web site from another site, PanAgora Asset Management and its affiliates are not responsible for the accuracy of information contained within the sites of other providers who have links to any pages of this Web site. By proceeding into this Web site, you agree to the exclusion by PanAgora Asset Management and its affiliates of any liability in respect of any errors or omissions.